Adam D Irwin1, Alison Grant2, Rhian Williams2, Ruwanthi Kolamunnage-Dona3, Richard J Drew4,5, Stephane Paulus6, Graham Jeffers7, Kim Williams2, Rachel Breen8, Jennifer Preston7, Duncan Appelbe8, Christine Chesters9, Paul Newland9, Omnia Marzouk2, Paul S McNamara7, Peter J Diggle10,11, Enitan D Carrol10. 1. Institute of Infection and Global Health, adam.irwin@nhs.net. 2. Departments of Emergency. 3. Department of Biostatistics. 4. Department of Microbiology, Rotunda Hospital, Dublin, Ireland. 5. Department of Microbiology, Royal College of Surgeons in Ireland, Dublin, Ireland; and. 6. Infectious Disease, and. 7. Institute of Translational Medicine, and. 8. Clinical Trials Research Centre, University of Liverpool, Liverpool, United Kingdom. 9. Biochemistry, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom. 10. Institute of Infection and Global Health. 11. Centre for Health Informatics, Computing, and Statistics, Lancaster University, Lancaster, United Kingdom.
Abstract
BACKGROUND: Improving the diagnosis of serious bacterial infections (SBIs) in the children's emergency department is a clinical priority. Early recognition reduces morbidity and mortality, and supporting clinicians in ruling out SBIs may limit unnecessary admissions and antibiotic use. METHODS: A prospective, diagnostic accuracy study of clinical and biomarker variables in the diagnosis of SBIs (pneumonia or other SBI) in febrile children <16 years old. A diagnostic model was derived by using multinomial logistic regression and internally validated. External validation of a published model was undertaken, followed by model updating and extension by the inclusion of procalcitonin and resistin. RESULTS: There were 1101 children studied, of whom 264 had an SBI. A diagnostic model discriminated well between pneumonia and no SBI (concordance statistic 0.84, 95% confidence interval 0.78-0.90) and between other SBIs and no SBI (0.77, 95% confidence interval 0.71-0.83) on internal validation. A published model discriminated well on external validation. Model updating yielded good calibration with good performance at both high-risk (positive likelihood ratios: 6.46 and 5.13 for pneumonia and other SBI, respectively) and low-risk (negative likelihood ratios: 0.16 and 0.13, respectively) thresholds. Extending the model with procalcitonin and resistin yielded improvements in discrimination. CONCLUSIONS: Diagnostic models discriminated well between pneumonia, other SBIs, and no SBI in febrile children in the emergency department. Improvements in the classification of nonevents have the potential to reduce unnecessary hospital admissions and improve antibiotic prescribing. The benefits of this improved risk prediction should be further evaluated in robust impact studies.
BACKGROUND: Improving the diagnosis of serious bacterial infections (SBIs) in the children's emergency department is a clinical priority. Early recognition reduces morbidity and mortality, and supporting clinicians in ruling out SBIs may limit unnecessary admissions and antibiotic use. METHODS: A prospective, diagnostic accuracy study of clinical and biomarker variables in the diagnosis of SBIs (pneumonia or other SBI) in febrile children <16 years old. A diagnostic model was derived by using multinomial logistic regression and internally validated. External validation of a published model was undertaken, followed by model updating and extension by the inclusion of procalcitonin and resistin. RESULTS: There were 1101 children studied, of whom 264 had an SBI. A diagnostic model discriminated well between pneumonia and no SBI (concordance statistic 0.84, 95% confidence interval 0.78-0.90) and between other SBIs and no SBI (0.77, 95% confidence interval 0.71-0.83) on internal validation. A published model discriminated well on external validation. Model updating yielded good calibration with good performance at both high-risk (positive likelihood ratios: 6.46 and 5.13 for pneumonia and other SBI, respectively) and low-risk (negative likelihood ratios: 0.16 and 0.13, respectively) thresholds. Extending the model with procalcitonin and resistin yielded improvements in discrimination. CONCLUSIONS: Diagnostic models discriminated well between pneumonia, other SBIs, and no SBI in febrile children in the emergency department. Improvements in the classification of nonevents have the potential to reduce unnecessary hospital admissions and improve antibiotic prescribing. The benefits of this improved risk prediction should be further evaluated in robust impact studies.
Authors: Sam T Romaine; Jessica Potter; Aakash Khanijau; Rachel J McGalliard; Jemma L Wright; Gerri Sefton; Simon Leigh; Karl Edwardson; Philip Johnston; Anne Kerr; Luregn J Schlapbach; Philip Pallmann; Enitan D Carrol Journal: Pediatrics Date: 2020-10 Impact factor: 7.124
Authors: Sietske C van Nassau; Ron H van Beek; Gertjan J Driessen; Jan A Hazelzet; Herbert M van Wering; Navin P Boeddha Journal: Front Pediatr Date: 2018-10-01 Impact factor: 3.418
Authors: Chantal van Houten; Josephine Sophia van de Maat; Christiana Naaktgeboren; Louis Bont; R Oostenbrink Journal: BMJ Paediatr Open Date: 2019-09-20
Authors: Josephine S van de Maat; Daphne Peeters; Daan Nieboer; Anne-Marie van Wermeskerken; Frank J Smit; Jeroen G Noordzij; Gerdien Tramper-Stranders; Gertjan J A Driessen; Charlie C Obihara; Jeanine Punt; Johan van der Lei; Suzanne Polinder; Henriette A Moll; Rianne Oostenbrink Journal: PLoS Med Date: 2020-01-31 Impact factor: 11.069
Authors: Marjolein J C Schot; Anne R J Dekker; Wesley G Giorgi; Rogier M Hopstaken; Niek J de Wit; Theo J M Verheij; Jochen W L Cals Journal: NPJ Prim Care Respir Med Date: 2018-10-26 Impact factor: 2.871
Authors: Elles M F van de Voort; Santiago Mintegi; Alain Gervaix; Henriette A Moll; Rianne Oostenbrink Journal: Front Pediatr Date: 2018-10-08 Impact factor: 3.418
Authors: Simon Leigh; Alison Grant; Nicola Murray; Brian Faragher; Henal Desai; Samantha Dolan; Naeema Cabdi; James B Murray; Yasmin Rejaei; Stephanie Stewart; Karl Edwardson; Jason Dean; Bimal Mehta; Shunmay Yeung; Frans Coenen; Louis W Niessen; Enitan D Carrol Journal: BMC Med Date: 2019-03-06 Impact factor: 8.775